Form 4: General Atlantic Sells 17 Million Shares of Alignment Healthcare (ALHC) at $15.28 Per Share

Sentiment:

SEC Form 4 Filing


General Atlantic, a major shareholder in Alignment Healthcare, sold 17 million shares of common stock at $15.28 per share on May 19, 2025.

Summary

  • General Atlantic, L.P. and affiliated entities, including General Atlantic GenPar, L.P., General Atlantic Partners 95, L.P., GAP Coinvestments III, LLC, GAP Coinvestments IV, LLC, GAP Coinvestments V, LLC, GAPCO GmbH & Co. KG, GAPCO Management GmbH, GAP Coinvestments CDA, L.P., and General Atlantic (SPV) GP, LLC, filed a Form 4.
  • The filing reports a sale of 17,000,000 shares of Alignment Healthcare, Inc. (ALHC) common stock by General Atlantic (ALN HLTH), L.P. on May 19, 2025.
  • The shares were sold in an open market transaction at a price of $15.28 per share.
  • Following the transaction, General Atlantic (ALN HLTH), L.P. directly holds 43,993,323 shares of ALHC common stock.
  • Indirect ownership includes shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P. by Nicholas Robbert Vorhoff and David C. Hodgson.
  • The reporting persons disclaim beneficial ownership of securities not directly owned, and the report is not an admission of group membership or beneficial ownership.
  • Each reporting person is a director-by-deputization solely for purposes of Section 16 of the Exchange Act.

Sentiment

Score: 5

Explanation: Neutral sentiment. The document simply reports a transaction. The sale of shares by a major holder could be perceived negatively, but it doesn't necessarily indicate a problem with the company's fundamentals.

Negatives

  • The sale of a significant number of shares by a major shareholder like General Atlantic could create short-term negative pressure on the stock price.

Risks

  • Further sales by General Atlantic could continue to put downward pressure on the stock price.
  • Market perception of General Atlantic's reduced stake could negatively impact investor confidence.

Future Outlook

The document does not contain specific forward-looking statements regarding Alignment Healthcare's future performance, but the sale of shares by a major holder could influence market sentiment.

Industry Context

Sales of shares by major holders are common and can be driven by various factors, including portfolio rebalancing or profit-taking. The impact on Alignment Healthcare will depend on market perception and the company's underlying performance.

Comparison to Industry Standards

  • It is difficult to compare this transaction to industry standards without knowing the specific reasons behind General Atlantic's sale.
  • Large institutional investors like General Atlantic often adjust their holdings based on internal investment strategies and market conditions.
  • Comparable transactions would involve analyzing similar sales by major shareholders in other healthcare companies.

Key Dates

DateDescription
05/19/2025Date of the transaction: sale of 17,000,000 shares of Common Stock
05/21/2025Date of Form 4 filing

Keywords

Alignment Healthcare, ALHC, General Atlantic, Share Sale, Form 4, Beneficial Ownership, Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.